血清白细胞介素-6的变化无法识别二期翻修治疗假体周围感染患者后续发生的假体周围感染
该单中心回顾性研究纳入125例因慢性膝关节或髋关节假体周围感染行计划性二期翻修的患者,分析再植入前血清C反应蛋白和白细胞介素-6及其两期之间变化对后续假体周围感染的识别价值。结果显示再植入前C反应蛋白和白细胞介素-6在后续感染患者中较高,但敏感性低至中等、特异性良好,且两期之间变化无组间差异,作者认为其作为排除试验的价值存疑。
要点
- 再植入前C反应蛋白和白细胞介素-6在后续假体周围感染患者中较高。
- 再植入前C反应蛋白和白细胞介素-6敏感性低至中等、特异性良好。
- 两期之间C反应蛋白和白细胞介素-6的变化未能识别后续假体周围感染。
核心结论
- 再植入前血清C反应蛋白和白细胞介素-6诊断后续假体周围感染的敏感性低至中等、特异性良好,其作为排除试验的价值存疑。
- 两期之间C反应蛋白和白细胞介素-6的变化似乎不能识别后续假体周围感染。
研究设计与样本
- 单中心回顾性识别125例因慢性膝关节或髋关节假体周围感染行计划性二期翻修的患者。
- 纳入条件为两期术前C反应蛋白和白细胞介素-6均可获得。
- 后续假体周围感染定义为再植入或后续手术时2次阳性微生物培养,或随访期间死于假体周围感染。
主要发现
- 再植入前中位血清C反应蛋白在后续感染患者中全膝关节置换术组为1.0 mg/dL vs 0.5 mg/dL(P = .028),全髋关节置换术组为1.3 mg/dL vs 0.5 mg/dL(P = .015)。
- 再植入前中位血清白细胞介素-6在后续感染患者中全膝关节置换术组为8.0 pg/mL vs 6.0 pg/mL(P = .052),全髋关节置换术组为7.0 pg/mL vs 6.0 pg/mL(P = .239)。
- 敏感性:全膝关节置换术/C反应蛋白66.7%,全髋关节置换术/C反应蛋白58.8%,全膝关节置换术/白细胞介素-6 46.7%,全髋关节置换术/白细胞介素-6 35.3%。
- 特异性:全膝关节置换术/C反应蛋白66.7%,全髋关节置换术/C反应蛋白81.0%,全膝关节置换术/白细胞介素-6 86.3%,全髋关节置换术/白细胞介素-6 83.3%。
- 两期之间C反应蛋白和白细胞介素-6的变化在组间无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The diagnosis of persistent infection prior to second-stage reimplantation in 2-stage exchanges for periprosthetic joint infection (PJI) can be challenging as there is no optimal diagnostic tool. This study investigates the usefulness of pre-reimplantation serum C-reactive protein (CRP) and interleukin-6 (IL-6) and its change between both stages to identify patients who have subsequent PJI. METHODS: There were 125 patients who underwent planned 2-stage exchange for chronic knee or hip PJI from a single center retrospectively identified. Patients were included if preoperative CRP and IL-6 were available for both stages. Subsequent PJI was defined as 2 positive microbiological cultures at reimplantation or subsequent surgery or death due to PJI during follow-up. RESULTS: Prior to reimplantation, the median serum CRP (total knee arthroplasties [TKAs]: 1.0 versus 0.5 mg/dL, P = .028; total hip arthroplasties [THAs]: 1.3 versus 0.5 mg/dL, P = .015) and median IL-6 (TKA: 8.0 versus 6.0 pg/mL, P = .052; THA: 7.0 versus 6.0 pg/mL, P = .239) were higher in patients who had subsequent PJI. The IL-6 and CRP values showed moderate sensitivity (TKA/CRP: 66.7%; THA/CRP: 58.8%; TKA/IL-6: 46.7%; THA/IL-6: 35.3%) and good specificity (TKA/CRP: 66.7%; THA/CRP: 81.0%; TKA/IL-6: 86.3%; THA/IL-6: 83.3%). The change in CRP and IL-6 between the stages did not differ between the groups, respectively. CONCLUSIONS: Serum CRP and IL-6 show low to moderate sensitivity and good specificity in the diagnosis of subsequent PJI prior to reimplantation, which questions their usefulness as a rule-out test. Furthermore, the change in between stages does not appear to identify subsequent PJI.
引用
- Krueger JS, Ackmann T, Gosheger G, et al. The Change of Serum Interleukin-6 Fails to Identify Subsequent Periprosthetic Joint Infection in Patients Who Have Two-Stage Revision for Periprosthetic Joint Infection. J Arthroplasty. 2023. PMID: 37315631. doi:10.1016/j.arth.2023.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。